Aclaris therapeutics to participate in two november healthcare investor conferences

Wayne, pa., nov. 10, 2022 (globe newswire) -- aclaris therapeutics, inc. (nasdaq: acrs), a clinical-stage biopharmaceutical company focused on developing novel drug candidates for immuno-inflammatory diseases, today announced that the company will participate in two november healthcare investor conferences.

ACRS Ratings Summary

ACRS Quant Ranking